Biogen Idec (NASDAQ: BIIB) and Elan Corporation (NYSE: ELN) report one-year data from the Phase III SENTINEL trial demonstrated that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE